ULTOMIRIS conc perf 1100 mg/11ml flac 11 ml
7680672780030
CH-67278
L04AA43
07.15.0.
Reimbursement limitations:
ULTOMIRI.PNH
Traitement des adultes atteints avec Hémoglobinurie Paroxystique Nocturne (HPN)
Avant le début du traitement, une …
1 / 3
google
Details
- Product number
- 6727803
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ravulizumabum 1100 mg, natrii dihydrogenophosphas, dinatrii phosphas, argininum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 11 ml corresp. natrium 16.8 mg.
Articles (1)
Ultomiris 1100 mg/11 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
16.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 15221.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2022
Authorization holder
Alexion Pharma GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 67278
- Drug name
- Ultomiris, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L04AA43
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/01/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ULTOMIRIS conc perf 1100 mg/11ml flac 11 ml
- Description (DE)
- ULTOMIRIS Inf Konz 1100 mg/11ml Durchstf 11 ml
- Market launch
- 16/09/2021
- Narcotic (BTM)
- No